609780-49-6 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
4-(4-Carbamoyl-phenylcarbamoyl)-piperidine is used as a chemical intermediate for the synthesis of pharmaceutical compounds due to its potential biological activity. Its unique structure allows it to be a promising candidate in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Organic Chemistry:
In the field of organic chemistry, 4-(4-Carbamoyl-phenylcarbamoyl)-piperidine is used as a building block for the synthesis of more complex organic molecules. Its versatile structure and reactivity make it a valuable component in creating a wide range of chemical entities, from advanced materials to novel therapeutic agents.
Used in Chemical Synthesis:
4-(4-Carbamoyl-phenylcarbamoyl)-piperidine is employed as a key component in the synthesis of various chemical compounds. Its presence in the molecular structure can influence the properties and reactivity of the final product, making it an essential ingredient in the creation of new chemical entities with specific applications.
Used in Medicinal Chemistry:
In medicinal chemistry, 4-(4-Carbamoyl-phenylcarbamoyl)-piperidine is utilized as a scaffold for the design and development of new pharmaceutical agents. Its structural features can be modified to optimize the compound's interaction with biological targets, potentially leading to the discovery of more effective and safer medications.
Check Digit Verification of cas no
The CAS Registry Mumber 609780-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,9,7,8 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 609780-49:
(8*6)+(7*0)+(6*9)+(5*7)+(4*8)+(3*0)+(2*4)+(1*9)=186
186 % 10 = 6
So 609780-49-6 is a valid CAS Registry Number.
609780-49-6Relevant academic research and scientific papers
BENZAMIDE DERIVATIVES
-
Page 19, (2010/02/10)
A compound represented by formula (1): wherein X is a single bond or a substituted or unsubstituted lower alkylene group; Z is a saturated or unsaturated monocyclic hydrocarbon ring group or the like; and each of R1, R2, R3 and R4, which may be the same or different, is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug has inhibitory effect on Rho kinase and hence is useful for treating diseases which are such that morbidity due to them is expected to be improved by inhibition of Rho kinase and secondary effects such as inhibition of the Na+/H+ exchange transport system caused by the Rho kinase inhibition, for example, hypertension.
